Mountain Valley MD Holdings Inc. announced it has contracted Tulane University School of Medicine in New Orleans, Louisiana, United States, as its Contract Research Organization ("CRO") to conduct its adjuvant Inactivated Polio Vaccine ("IPV") study, commencing in February 2021.